CDKAL1 c.287-26771C>T

Variant ID: 6-20622753-C-T

NM_017774.3(CDKAL1):c.287-26771C>T

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Transactions Of The American Ophthalmological Society
Francis, Peter James PJ
Publication Date: 2011-12

Variant appearance in text: rs1569660
PubMed Link: 22253485
Variant Present in the following documents:
  • Main text
View BVdb publication page



Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians.

Diabetes
Rong, Rong R; Hanson, Robert L RL; Ortiz, Daniel D; Wiedrich, Christopher C; Kobes, Sayuko S; Knowler, William C WC; Bogardus, Clifton C; Baier, Leslie J LJ
Publication Date: 2009-02

Variant appearance in text: rs1569660
PubMed Link: 19008344
Variant Present in the following documents:
  • Main text
  • 478.pdf
View BVdb publication page